With BioNeMo, we can pre-train large language models for molecular biology on Amgen’s proprietary data, enabling us to explore and develop therapeutic proteins for the upcoming generation of medicines that will benefit patients, according to Peter Grandsard, executive director of Biologics Therapeutic Discovery at Amgen.
Six models, including DeepMind’s AlphaFold2, Meta AI’s ESM2 and ESMFold, DiffDock, and MoFlow, will be made available at launch.According to the companies, utilising AI-based predictive models helped cut the time to train “five custom models for molecule screening and optimisation” using Amgen’s proprietary data on antibodies from the customary three months down to four weeks.
The photography website will employ Picasso to create 3D things from text prompts as a new tool within Creative Flow, with plans to make it available on Turbosquid.com and NVIDIA’s upcoming Omniverse platform, according to a similar agreement that NVIDIA announced with Shutterstock.
